We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Differentiated Thyroid Cancer (DTC) is the most common type, characterized by cancer cells resembling normal thyroid cells. Learn about its types, symptoms, causes, diagnosis, treatment, and excellent prognosis.
Understanding Differentiated Thyroid Cancer (DTC) The thyroid gland, a small butterfly-shaped organ located at the base of your neck, plays a crucial role in regulating your body's metabolism by producing hormones. When abnormal cells grow uncontrollably in this gland, it leads to thyroid cancer. Among the different types of thyroid cancer, Differentiated Thyroid Cancer (DTC) stands out as the most common, accounting for over 90% of all cases. The term 'differentiated' signifies that these cancer cells, when viewed under a microscope, closely resemble normal thyroid cells. This characteristic often implies a slower growth rate and a more favorable prognosis compared to other, less differentiated forms of thyroid cancer. Types of Differentiated Thyroid Cancer DTC is primarily categorized based on the specific type of thyroid cell from which it originates. The main types include: Papillary Thyroid Cancer (PTC): This is the most prevalent form, making up about 80% to 85% of all thyroid cancers. PTC typically grows slowly and has an excellent outlook, especially when detected early. Follicular Thyroid Cancer (FTC): Accounting for approximately 10% to 15% of thyroid cancers, FTC also tends to grow slowly. However, it has a greater tendency to spread through the bloodstream to distant organs like the lungs and bones. Hürthle Cell Thyroid Cancer: This rarer subtype, representing about 3% of thyroid cancers, originates from follicular cells. Historically, it was considered a variant of FTC, but it is now often classified separately due to its unique characteristics. It's important to distinguish DTC from other types of thyroid cancer, such as poorly differentiated thyroid cancer (PDTC) and undifferentiated thyroid cancer (UTC), which includes anaplastic thyroid cancer. These less differentiated cancers are generally more aggressive and harder to treat. Symptoms of Differentiated Thyroid Cancer In its early stages, DTC often presents with no noticeable symptoms. Many cases are discovered incidentally during routine medical check-ups or imaging tests for other conditions. However, as the cancer grows, certain signs may emerge: A lump or swelling in the neck, which may or may not be painful. Changes in voice, such as hoarseness. Difficulty swallowing or breathing. Persistent cough not related to a cold. Swollen lymph nodes in the neck. It is crucial to remember that these symptoms can also be caused by non-cancerous conditions, such as goiters or thyroid nodules. Therefore, consulting a doctor for a proper diagnosis is essential. Causes and Risk Factors The exact cause of DTC is not fully understood, but certain factors are known to increase the risk of developing it: Exposure to Radiation: Previous exposure to radiation, particularly during childhood or adolescence (e.g., from medical treatments like radiation therapy for other cancers or nuclear accidents), is a significant risk factor. Iodine Deficiency: While less common in regions with adequate iodine intake, severe iodine deficiency has been linked to an increased risk of certain thyroid cancers. Family History: Having a family history of thyroid cancer or certain genetic syndromes (like Multiple Endocrine Neoplasia type 2) can increase your susceptibility. Age: While thyroid cancer can occur at any age, it is more commonly diagnosed in individuals between the ages of 25 and 65. Gender: Women are more likely to develop thyroid cancer than men. Diagnosis of Differentiated Thyroid Cancer Diagnosing DTC typically involves a multi-step process: Medical History and Physical Examination: Your doctor will ask about your symptoms, medical history, and family history, and perform a physical examination, paying close attention to your neck. Thyroid Function Tests: Blood tests are conducted to measure the levels of thyroid hormones (T3, T4) and thyroid-stimulating hormone (TSH) to assess overall thyroid function. Ultrasound of the Neck: This is the primary imaging technique used to evaluate thyroid nodules. It helps determine the size, shape, and characteristics of any lumps and whether they are solid or cystic. Fine-Needle Aspiration (FNA) Biopsy: If an ultrasound reveals a suspicious nodule, an FNA biopsy is performed. A thin needle is used to extract a small sample of cells from the nodule, which are then examined under a microscope by a pathologist to check for cancer cells. Thyroid Scan: In some cases, a thyroid scan using radioactive iodine may be used to assess how the thyroid gland is functioning and whether a nodule is taking up iodine. Imaging Tests: CT scans or MRI scans may be used to determine the extent of the cancer if it has spread. Treatment Options for Differentiated Thyroid Cancer The treatment approach for DTC is highly personalized and depends on factors such as the type of cancer, its size, stage, and whether it has spread. The primary treatment modalities include: Surgery: This is the cornerstone of DTC treatment. The type of surgery depends on the cancer's extent: Thyroidectomy: Removal of all or part of the thyroid gland. A lobectomy (removal of one lobe) may be sufficient for small, early-stage cancers, while a total thyroidectomy (removal of the entire gland) is often recommended for larger or more advanced cancers. Lymph Node Dissection: If cancer has spread to the lymph nodes in the neck, these nodes may also be surgically removed. Radioactive Iodine (RAI) Therapy: Following surgery, RAI therapy is often used to destroy any remaining thyroid tissue or cancer cells, particularly if the cancer has spread to lymph nodes or distant sites. This treatment is effective because thyroid cells, including cancer cells, absorb iodine. Thyroid Hormone Suppression Therapy: After a total thyroidectomy, patients will need to take thyroid hormone replacement medication (levothyroxine) for
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026